Lobe Sciences Ltd. announced that the appointment of Mr. Jonathan Gilbert as executive chairman of the board of directors. Jonathan Gilbert has over 20 years of leadership, capital raising and public markets expertise. He is considered one of the leaders in both the cannabis and emerging psychedelic sectors, having successfully co-founded and run several companies, leading them to successful M&A transactions. Jonathan originally joined the company's board of directors in July, 2020 in conjunction with the acquisition of Eleusian Biosciences Corp. which he was co-founder, CEO and director. He is an accomplished leader and business executive with several successful exits in the psychedelics and cannabis sector. Previously, he was the co-founder, CEO and director of SOL Global Investments Corp. (formerly Scythian Biosciences Corp.), a publicly traded research and development company focusing on the prevention and treatment of concussions and traumatic brain injury using a proprietary cannabinoid combination. He was also founder, CEO and a director of Tassili Life Sciences Corp., which was acquired by CSE-listed Champignon Brands Inc. in March 2020. Mr. Gilbert was also executive chairman of Exactus Inc., an OTC listed company focused on farming and production of hemp to be manufactured into cannabidiol (CBD) related products.